Financial Performance - Total revenues for Q1 2025 were $926,932,000, a 47.6% increase from $628,601,000 in Q1 2024[19] - Earned premiums increased to $918,043,000 in Q1 2025, up 47.8% from $621,556,000 in Q1 2024[19] - The net loss for Q1 2025 was $9,354,000, significantly improved from a net loss of $46,575,000 in Q1 2024[19] - Adjusted EBITDA for the first quarter of 2025 was $20,178, a significant recovery from a loss of $11,980 in the same period of 2024, marking a 268.4% improvement[146] - The net loss decreased by 79.9%, from $46,575 in Q1 2024 to $9,354 in Q1 2025, indicating improved financial performance[146] Medical Expenses - Medical expenses rose to $820,900,000 in Q1 2025, compared to $573,218,000 in Q1 2024, reflecting a 43.3% increase[19] - Medical expenses for the same period were $819,715, up from $572,033 in 2024, indicating a 43.3% rise[36] - Medical expenses rose to $820.9 million, an increase of 43.2% from $573.2 million in the prior year, primarily due to the growth in Health Plan membership[162] - The medical benefits ratio (MBR) improved to 88.4% in 2025 from 90.9% in 2024, reflecting better management of healthcare expenditures[146] Cash and Liquidity - Cash and cash equivalents at the end of Q1 2025 were $446,184,000, up from $432,859,000 at the end of Q4 2024[17] - Cash, cash equivalents, and restricted cash at the end of the period were $448.3 million, up from $241.1 million at the end of the same period in 2024[183] - The company had $479.5 million in cash, cash equivalents, and short-term investments as of March 31, 2025, indicating strong liquidity[168] Assets and Liabilities - Total assets increased to $895,617,000 as of March 31, 2025, compared to $782,063,000 at the end of 2024, marking a 14.5% growth[17] - Total liabilities rose to $786,622,000 in Q1 2025, up from $681,108,000 at the end of 2024, indicating a 15.5% increase[17] - The company reported a total stockholders' equity of $108,995,000 as of March 31, 2025, compared to $100,955,000 at the end of 2024[17] Membership Growth - Health Plan Membership increased to 217,500 as of March 31, 2025, representing a 29% compound annual growth rate[135] - Health plan membership increased by 31.7% year-over-year, reaching 217,500 members as of March 31, 2025, compared to 165,100 in 2024[146] - The company operates in 45 markets across 5 states, targeting approximately 8.2 million Medicare-eligible seniors[137] Operational Developments - The company is focused on expanding its Medicare Advantage Plans across California, North Carolina, Nevada, Arizona, and Texas[29] - The proprietary technology platform, AVA, is expected to enhance member relationships and care quality, impacting future performance[139] - The company plans to invest in the AVA platform and pursue strategic acquisitions focused on healthcare delivery groups and Medicare Advantage plans[144] Regulatory and Compliance - The company is subject to a minimum annual medical loss ratio (MLR) of 85% for its Medicare Advantage Plans, with immaterial amounts payable under this provision as of March 31, 2025[46] - The company was in compliance with Risk-Based Capital (RBC) and Tangible Net Equity (TNE) requirements as of March 31, 2025[120] - As of March 31, 2025, the company was in compliance with minimum capital requirements set by states where it operates[174] Expenses and Costs - Selling, general and administrative expenses increased by 14.7% to $103.8 million, attributed to investments in network development and marketing[163] - Interest expense decreased by 25.9% to $4.0 million due to a reduction in the interest rate on debt following refinancing[165] - The company experienced modest increases in unit costs and labor expenses but believes inflation has not had a material effect on operating results[201] Legal and Settlement Matters - The company has accrued a potential liability of $913 related to a tentative settlement of a class action lawsuit as of March 31, 2025[125] Management Changes - The company appointed James Head as the new Chief Financial Officer effective May 2, 2025, succeeding Thomas Freeman[215]
Alignment Healthcare(ALHC) - 2025 Q1 - Quarterly Report